Michael Cline Net Worth, How Much Money Is Michael Cline Worth?

As of July 17, 2024, the estimated net worth of J Michael Cline is at least $0. J Michael Cline is known as the 10% owner of NeoMedia Technologies Inc, but currently, he holds about 0 shares of NeoMedia Technologies Inc (NEOM) stock, making his current net worth $0 based on these holdings.

Who is J Michael Cline?

J Michael Cline is recognized for his involvement with NeoMedia Technologies Inc, where he holds a significant ownership stake. However, recent reports indicate that he no longer owns any shares in the company. His financial standing is derived from SEC filings, which suggest that he hasn’t made any stock transactions since March 18, 2011.

What are NeoMedia Technologies Inc and Its Impact on J Michael Cline’s Net Worth?

NeoMedia Technologies Inc is a company that has been pivotal in the development of mobile barcode technology. Despite its innovative contributions, the company’s stock performance has not been favorable, which has reflected in J Michael Cline’s current net worth estimation.

How Accurate are Insider Trading Reports?

The insider trading information, including J Michael Cline’s holdings, comes from SEC filings. These reports are based on the last recorded transactions and holdings. Therefore, the net worth estimation assumes that no further transactions have occurred since the last filing date in 2011.

What is the Trading Activity at Accolade?

Over the past four years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock. Notable traders include Edgar Jr Bronfman, Jeffrey D Jordan, and Dawn G Lepore. The most recent trade was by Stephen H. Barnes, who traded 770 units of ACCD stock on July 10, 2024, worth $2,957.

Who are the Most Active Insiders at Accolade?

The most active insiders at Accolade include Edgar Jr Bronfman, Jeffrey D Jordan, and Dawn G Lepore. These individuals have engaged in frequent trading activities, significantly impacting the company’s stock transactions. On average, Accolade executives and independent directors trade stock every five days, with each trade averaging around $19,334.

What Does Accolade Do?

Accolade, Inc. is a company that provides technology-enabled solutions to help people navigate and utilize the healthcare system and workplace benefits in the United States. Their platform integrates cloud-based technology with support from health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. Accolade also offers second opinion consultations and healthcare decision support services.

How Does Accolade Support Employers and Employees?

Accolade serves employers by offering their employees a centralized platform to manage health, healthcare, and benefits needs. This service aims to simplify the healthcare experience and improve outcomes by providing personalized support and guidance from a team of healthcare professionals.

What is the History and Location of Accolade?

Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. The company’s mission is to provide comprehensive support to individuals navigating the complex healthcare landscape, ensuring they receive the best possible care and benefits.

What are the Recent Developments at Accolade?

Accolade has been actively involved in enhancing its platform and expanding its services to better meet the needs of its clients. The company’s recent stock trades and continuous efforts to innovate in the healthcare sector highlight its commitment to improving the healthcare experience for its users.

Why is Insider Trading Information Important?

Insider trading information provides insights into the buying and selling activities of a company’s executives and directors. This information can be valuable for investors as it reflects the confidence and outlook of those who are most familiar with the company’s operations and future prospects.

Conclusion

The net worth of J Michael Cline, once a notable figure in NeoMedia Technologies Inc, stands at $0 as of mid-2024 due to his current holdings. Meanwhile, Accolade continues to make significant strides in the healthcare sector, with active insider trading and a strong focus on improving healthcare navigation and benefits management for employers and employees alike. These developments underscore the dynamic nature of both individuals and companies in the ever-evolving business landscape.

Leave a Comment